Immunocore Holdings Ltd (IMCR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.55B
Last updated: Nov 17, 2026 at 4:10 PM ET
Immunocore Holdings Ltd (IMCR) Stock Chart
Immunocore Holdings (IMCR) has a latest price of $27.81 on Nov 17, 2026, 31.7% below its 52-week high of $40.71. Its price fell 22.6% over the past 12 months. The month-end price fell 20.8% over the 5 years through Oct 2026, a compound annual decline of 4.6%.
Price Chart
From Feb 2021 to Oct 2026, its highest month-end close was $72.29 in Jan 2024 and its lowest $22.10 in Feb 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IMCR with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IMCR.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 24.6%, and over 6 months it fell 3.9%. The month-end price fell 31.3% over the 3 years through Oct 2026, a compound annual decline of 11.8%.
| Period | Change |
|---|---|
| 1 month | -6.8% |
| 3 months | -24.6% |
| 6 months | -3.9% |
| 12 months | -22.6% |
| 12 months, with dividends | -22.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -31.3% | -11.8% |
| 5 years | -20.8% | -4.6% |
Price by Year
Its best calendar year was 2022, when the price rose 66.7%, and its weakest was 2024, when it fell 56.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $30.49 | -12.2% |
| 2025 | $34.71 | +17.7% |
| 2024 | $29.50 | -56.8% |
| 2023 | $68.32 | +19.7% |
| 2022 | $57.07 | +66.7% |
Trading Range
The price is 9.6% below its 50-day average of $30.77 and 11.8% below its 200-day average of $31.54.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $27.81 | |
| 52-week high | $40.71 | -31.7% |
| 52-week low | $27.50 | +1.1% |
| 50-day average | $30.77 | -9.6% |
| 200-day average | $31.54 | -11.8% |
Price Risk
Over 3 years, its largest fall from a peak was 67.5%.
| Measure | Value |
|---|---|
| 1-year beta | 0.65 |
| Largest fall, 1 year | -30.9% |
| Largest fall, 3 years | -67.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IMCR
What is IMCR's 1-year price change?
Immunocore Holdings's price fell 22.6% over the past 12 months. With dividends included, the 12-month total return was -22.6%.
What is IMCR's 5-year price change?
Immunocore Holdings's month-end price fell 20.8% over the 5 years through Oct 2026, a compound annual decline of 4.6%. These figures leave out dividends.
What is IMCR's 52-week high and low?
Immunocore Holdings's 52-week high is $40.71 and its 52-week low is $27.50. Its latest price of $27.81 on Nov 17, 2026 is 31.7% below the high.
What is IMCR's beta?
Immunocore Holdings's 1-year beta against the S&P 500 is 0.65, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 30.9%.
Is the IMCR chart free?
Yes. Advanced Charting for IMCR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IMCR pages: Overview, Charting, Statistics, Valuation, Competitors, Government Contracts